A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT05899361
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Electromagnetic Guided Laparoscopy — DEVICE
    Standard Care
  • Ultrasound — DEVICE
    Standard Care

Study Details

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.

Key Dates

Start date
Aug 30, 2023
Status verified
Oct 2023
Primary completion
Aug 26, 2025
Completion
Dec 25, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Electromagnetic Guided Laparoscopy + Ultrasound
    This trial will investigate the use of the novel imaging protocol patients who have a confirmed cancer diagnosis in any of the following urologic regions or organs: Bladder, Prostate, Testicle, Ureter, Kidney, Urethra, Penis, and Scrotum. \- This research study involves the use of a standard of care laparoscope and ultrasound probe. The laparoscope and ultrasound probe will have an electromagnetic sensor attached which will assist in the tracking of lymph nodes of interest or organs of interest. It is expected that the entire time to record the data will be less than 10 minutes. standard of care laparoscope and ultrasound probe

Primary Outcome Measure

Laparoscope Images [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115
Matthew Mossanen, MD
[email protected]
617-732-6384
Matthew Mossanen, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By condition
Bladder cancerKidney cancerProstate cancer
By specialty
OncologyUrologyProstate oncologyMen's health
By research site
Brigham and Women's Hospital· Boston, MA

Related Studies